Terumo Corp. Hits Day High with Strong 3.05% Intraday Surge

Terumo Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable uptick in its stock performance today, gaining 3.05% as of February 27, 2026. The stock reached an intraday high of JPY 2,110.00, showcasing a significant rebound amid a broader market context where the Japan Nikkei 225 index declined by 1.12%. Over the past week, Terumo Corp. has demonstrated a robust performance with a 7.54% increase, contrasting sharply with the Nikkei's slight drop of 0.2%. However, the company's longer-term performance reveals challenges, with a year-to-date decline of 7.05% and a substantial 21.33% decrease over the past year. Despite these setbacks, Terumo Corp. has shown resilience in its operational metrics, including a strong EBIT to Interest ratio of 36.60, indicating a solid capacity to manage its debt. The company's net sales have grown at an annual rate of 10.50%, reflecting healthy long-term growth potential. With a market capitalization of JPY 3,260,192 million, Terumo Corp. continues to navigate a competitive landscape while maintaining a price-to-book ratio of 2.81, suggesting an attractive valuation relative to its peers.